Fortress Biotech, Inc.
USD2.95
+0.19 (+6.88%)
CEO
Lindsay Allan Rosenwald
IPO Date
2011-11-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.90
Prev. Close
$2.76
Day Low
$2.73
Day High
$2.95
52W Low
$1.75
52W High
$4.53
Market Cap
$0.10B
Volume
0.53M
| -0.9 |
| 31 Dec 2023 | FY | 72.9% | -71.7% | -269.0% | -36.2% | 3.93 | 1.38 | -0.4 |
| 31 Dec 2022 | FY | 59.4% | -114.3% | -207.5% | -29.4% | 3.05 | 1.80 | -0.7 |
| 31 Dec 2021 | FY | 53.4% | -94.1% | -59.5% | -16.3% | 0.69 | 3.43 | -3.2 |
| 31 Dec 2020 | FY | 68.0% | -102.0% | -46.4% | -14.0% | 0.89 | 5.14 | -4.9 |
| 31 Dec 2019 | FY | 71.2% | -109.1% | -152.4% | -17.6% | 4.39 | 3.43 | -3.5 |
| 31 Dec 2018 | FY | 77.2% | -313.0% | -4543.6% | -59.7% | 42.93 | 2.00 | -0.4 |
| 31 Dec 2017 | FY | 14.1% | -35.7% | -127.2% | -27.2% | 1.19 | 2.56 | -2.5 |
| 31 Dec 2016 | FY | 31.1% | -334.3% | -143.1% | -32.3% | 0.73 | 1.94 | -2.0 |
| -6.5 |
| 30 Sept 2025 | Q3 | 67.4% | 33.2% | 10.5% | 3.2% | 1.22 | 2.19 | 4.3 |
| 30 Jun 2025 | Q2 | 69.9% | 94.4% | 35.3% | 9.7% | 1.58 | 1.92 | 0.8 |
| 31 Mar 2025 | Q1 | 63.5% | -80.6% | -47.6% | -5.9% | 3.34 | 1.72 | -1.0 |
| 31 Dec 2024 | Q4 | 61.6% | -44.7% | -29.8% | -4.7% | 3.34 | 1.27 | -1.5 |
| 30 Sept 2024 | Q3 | 63.9% | -88.0% | -60.8% | -10.1% | 3.38 | 1.23 | -0.6 |
| 30 Jun 2024 | Q2 | 56.1% | -73.5% | -61.2% | -7.5% | 4.95 | 1.37 | -0.7 |
| 31 Mar 2024 | Q1 | 53.9% | -118.3% | -67.0% | -9.4% | 3.85 | 1.33 | -0.6 |
| 31 Dec 2023 | Q4 | 69.8% | -46.5% | -41.2% | -5.5% | 3.93 | 1.38 | -0.6 |